Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,229 public trials 1,177 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT05089734

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Alaska Oncology and Hematology, LLC. Anchorage, Alaska, United States
  • USOR - Arizona Oncology Associates Tucson - Wilmot Tucson, Arizona, United States
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • Rocky Mountain Cancer Centers - Aurora Aurora, Colorado, United States
View all 227 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors

NCT05599984

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +20 more
Locations
  • Banner MD Anderson Cancer Ctr /ID# 260129 Gilbert, Arizona, United States
  • City Of Hope Comprehensive Cancer Center /ID# 271295 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 259884 Irvine, California, United States
  • Yale New Haven Hospital /ID# 246647 New Haven, Connecticut, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)

NCT05170204

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Northwest Cancer Specialists, P.C. Tigard, Oregon, United States
  • Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
View all 45 locations
View Trial Details
Active, Not Recruiting

PF-07104091 as a Single Agent and in Combination Therapy

NCT04553133

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +27 more
Locations
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Clive, Iowa, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer

NCT02417662

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLH London, England, United Kingdom
  • Belfast City Hospital Belfast, United Kingdom
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • Bristol Royal Infirmary Bristol, United Kingdom
View all 19 locations
View Trial Details
Active, Not Recruiting

A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

NCT03521154

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Florham Park, New Jersey, United States
  • Research Site Salt Lake City, Utah, United States
View all 118 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Ipilimumab Plus Chemotherapy for Patients With Stage IV Lung Cancer With Brain Metastases

NCT05012254

Conditions
Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +16 more
Locations
  • ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari Vall d' Hebron Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy

NCT06268613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • SB Investigative Site Gdansk, Poland
  • SB Investigative Site Otwock, Poland
  • SB Investigative Site Ansan, South Korea
  • SB Investigative Site Busan, South Korea
View all 24 locations
View Trial Details

Related conditions